Initial Triple Therapy Superior to Stepwise Add-On Therapy in Newly Diagnosed Type 2 Diabetes

Summary

Newly diagnosed patients with type 2 diabetes mellitus achieve lower HbA1C concentrations with a lower rate of hypoglycemia when started on triple therapy as opposed to stepwise add-on therapy. This article discusses results from a randomized open-label study comparing the two strategies.

  • Hyperglycemia/Hypoglycemia
  • Diabetes Mellitus
  • Diabetes & Endocrinology Clinical Trials
  • Hyperglycemia/Hypoglycemia
  • Endocrinology
  • Diabetes & Metabolic Syndrome
  • Diabetes Mellitus
  • Diabetes & Endocrinology Clinical Trials
View Full Text